TELMIVIB M 25TELMISARTAN 40mg. IP + METOPROLOL 25mg. IP

Telmivib M 25 tablets combine Telmisartan 40 mg and Metoprolol 25 mg to help treat high blood pressure. Main uses: treatment of high blood pressure (hypertension), to lower blood pressure; helps blood pressure control when a single medicine is not enough on its own; lowering blood pressure helps reduce the risk of stroke and heart attack.

Common side effects of Telmivib M 25 Tablet include tiredness; dizziness; headache; back pain; diarrhoea; slow heart rate. Get medical help at once if you notice harm to the developing baby if taken during pregnancy; very low blood pressure, especially in salt- or volume-depleted patients; severe slowing of the heart or heart block.

Each Telmivib M 25 tablet contains Telmisartan 40 mg + Metoprolol 25 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Telmivib M 25 Tablet only as your doctor advises.

The MRP of Telmivib M 25 Tablet is ₹130.31 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹99.28 and the PTS is ₹89.36.

Each Telmivib M 25 tablet contains Telmisartan 40 mg + Metoprolol 25 mg. It comes in a pack of 10x10 (Alu Alu).

Every tablet carries two active ingredients with different roles. Telmisartan blocks the effect of angiotensin II on blood vessels, allowing them to relax so that blood flows more easily. Metoprolol works mainly on the heart as a beta-1 selective blocker, slowing the heart rate and reducing the workload of the heart while it beats.

Must not be used in pregnancy; stop the medicine as soon as pregnancy is detected. Must not be used in patients allergic to telmisartan, metoprolol or any other component of the tablet. Must not be used in severe slow heart rate, second- or third-degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome without a pacemaker, or systolic blood pressure below 100 mmHg. Must not be co-administered with aliskiren in patients with diabetes. Beta-blockers like metoprolol should be avoided in bronchospastic disease such as asthma.

Telmivib M 25 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.